Diligence memo · auto-generated · as of July 2, 2026
Axon Therapies Inc.
Axon Therapies Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Axon Therapies Inc. operates in Other Technology, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Axon Therapies Inc. has raised $11M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $75M on 2019-01-23.
Most recent recorded round closed around 2019-01-23.
Valuation (modeled)modeled
Provath models Axon Therapies Inc. at approximately $208M (range $10M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.46× the median modeled value of Series A Other Technology companies in 2019–2021 (992 peers) — value vs value, same stage and era. Within the normal band (146% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 7.4 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 10.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 74% of Other Technology peers (21302 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Neighborhoods.com, LLC, tinyBuild Inc., DV01, Inc., NowSecure, Inc., Airbiquity Inc.
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.